Evidence map›Paper›PMID 36242889›Full record

ArticlePediatric neurology2022

Impact of COVID-19 Pandemic on Headache Evaluations in the Pediatric Emergency Department.

Alberto M Cappellari, Stefania Margiotta, Gaia Bruschi, Gianfranco Alicandro, Massimo Luca Castellazzi, Alessia Rocchi, Erica Venturelli, Giuseppe Bertolozzi

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pediatric neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alberto M CappellariDepartment of Neuroscience and Mental Health, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: alberto.cappellari@policlinico.mi.it.
Stefania MargiottaUniversità degli Studi di Milano, Milan, Italy.
Gaia BruschiUniversità degli Studi di Milano, Milan, Italy.
Gianfranco AlicandroDepartment of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy; Cystic Fibrosis Centre, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Massimo Luca CastellazziPediatric Emergency Department, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
Alessia RocchiPediatric Emergency Department, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
Erica VenturelliUniversità degli Studi di Milano, Milan, Italy.
Giuseppe BertolozziPediatric Emergency Department, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo evaluate the impact of COVID-19 on evaluations in the pediatric emergency department (ED) because of headache as main symptom.

methodsNumber and clinical features of patients evaluated in the pediatric ED of a single site in Milan, Italy, were collected between January 2017 and January 2022. The impact of COVID-19 on evaluation rates was quantified by using the incidence rate ratio (IRR) and 95% confidence intervals (CI) between the pandemic (March 2020 to January 2022) and the prepandemic period (January 2017 to February 2020).

resultsDuring the study period, 890 evaluations were registered: 689 over the prepandemic period and 201 over the pandemic period. Mean age at evaluation was 10 years (range: 1 to 17 years). Evaluation rates per month were 18.1 during the prepandemic period and 8.7 during COVID-19 pandemic, with peaks in autumn and winter months and considerable drops in the summer. The IRR was 0.49 (95% CI, 0.40-0.61). The reduction in evaluation rate was higher for secondary headache (IRR, 0.31; 95% CI, 0.23-0.42) when compared with primary headache (IRR, 0.56; 95% CI, 0.40-0.78).

conclusionsWe found a remarkable reduction in the number of evaluations in the pediatric ED for headache during the pandemic period.

Indexed as

COVID-19AdolescentChildChild, PreschoolEmergency Service, HospitalHeadacheHumansInfantPandemicsRetrospective StudiesSARS-CoV-2ChildrenEmergency departmentHeadacheInfectious diseasesNeurological disordersSARS-CoV-2

Identifiers

PMID36242889
PMCPMC9482084
OpenAlexW4296180115

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.